
Seikagaku commenced Taiwan launch of HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis, through TCM Biotech International.
The main ingredient of HyLink is a cross-linked hyaluronate hydrogel made using Seikagaku’s crosslinking technology. Since the highly viscoelastic hyaluronate hydrogel remains in the knee joint cavity for a long period of time, HyLink is expected to illicit a long-lasting improvement of symptoms by an administration of only 3 mL.
TCM is a pharmaceutical company with a nationwide sales network in Taiwan that has strengths in the fields of orthopedics and rehabilitation. In Taiwan, TCM exclusively distributes ARTZDispo® and Artzfors®, intra-articular multiple-injection viscosupplements manufactured by Seikagaku to treat knee osteoarthritis and rotator cuff lesions without complete tears.
Source: Seikagaku
Seikagaku commenced Taiwan launch of HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis, through TCM Biotech International.
The main ingredient of HyLink is a cross-linked hyaluronate hydrogel made using Seikagaku’s crosslinking technology. Since the highly viscoelastic hyaluronate hydrogel...
Seikagaku commenced Taiwan launch of HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis, through TCM Biotech International.
The main ingredient of HyLink is a cross-linked hyaluronate hydrogel made using Seikagaku’s crosslinking technology. Since the highly viscoelastic hyaluronate hydrogel remains in the knee joint cavity for a long period of time, HyLink is expected to illicit a long-lasting improvement of symptoms by an administration of only 3 mL.
TCM is a pharmaceutical company with a nationwide sales network in Taiwan that has strengths in the fields of orthopedics and rehabilitation. In Taiwan, TCM exclusively distributes ARTZDispo® and Artzfors®, intra-articular multiple-injection viscosupplements manufactured by Seikagaku to treat knee osteoarthritis and rotator cuff lesions without complete tears.
Source: Seikagaku
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





